U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07507734) titled 'Occlusal Splint and Exercise Therapy for Temporomandibular Disorders' on March 27. Brief S... Read More
U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07507994) titled 'COM-B Model-based Behavioral Intervention on Safe Pesticide Use and Food Safety Practice Am... Read More
U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07506954) titled 'Impact of Sound Shower Music Diffusion on Family Anxiety in Intensive Care Unit Waiting Roo... Read More
U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508488) titled 'Deucravacitinib in the Treatment of Cicatricial Alopecias' on March 18. Brief Summary: Thi... Read More
U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508436) titled 'Safety Planning Intervention for Autistic Youth: A Randomized Controlled Trial With Provide... Read More
U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508943) titled 'Decision-making and Optimization of Ventilatory Support for AECOPD Patients' on March 20. ... Read More
U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508462) titled 'A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydro... Read More
U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508605) titled 'Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma' on Marc... Read More
U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07506941) titled 'Study of Functional Decline and Care Pathways in Neurosurgical Patients Over 65 Years of Ag... Read More
U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07507760) titled 'Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients' on March ... Read More